Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2019 Donato Perez Garcia.

Saturday, April 20, 2019

Sugar, juicing and diets: How much sugar should you eat per day?

The information presented in this comment is solely responsible made by Dr. Donato Perez Garcia, MD., based on his personal experience of taking care of patients with chronic degenerative diseases and cancer since the year of 1982 (more than 36 years of experience in this field of alternative medicine). 

When you consume a healthy fresh juice of fruit or vegetable you lose fiber and that results in juices having the ability to spike your blood sugar in a more dramatic way than if you ate the actual fruit or vegetable. When juicing fruit and vegetables, some of the healthy, filling fiber is lost, because juice extractors separate the juice that contain concentrated amounts of vitamins, minerals and other plant nutrients from the fiber-rich pulp and skins. In addition to fiber, you also lose some polyphenols and antioxidants found in the pith of citrus fruits and skins of fruits and vegetables. Antioxidants help to balance inflammation, while enzymes (like the find in pineapple) help with digestion. Yes juicing can provide a convenient and refreshing way to get a dose of nutrients that are easily absorbed but juicing is not for everyone that has a chronic disease. 

Carbohydrates and sugar. 
All cells in our body rely on the presence of carbohydrates to function. If you do not provide the natural “fuel” to start the engine of each of your cells, functions like the one done by immune cells are not going to perform the job of keeping an eye on intruders and this will trigger a malfunction and eventually a disease. 
What is the problem with our diet?
It is not carbohydrates or protein or fat. The main problem is that we do not measure what are we going to eat in each meal. Want to start eating healthy? If yes this is what you need to do: measure what you are going to eat. Use a measuring cup or spoon. Our body needs are to consume balanced amounts of protein, fat and carbohydrates during the hours that we are awake.
Our body works better when we eat measured and balanced amounts of natural foods, preferably food that are grown on the specific season of the year. See the Food Calendar below (gives information about the beginning of the season and for several fruits and vegetables last for several months).

For the Northern Hemisphere, starting on:
March the fresh fruits and veggies are wild mushrooms.
April: parsnips and pea greens.
May: arugula, asparagus, Fava beans, lettuce, parsley, radishes, scallions/spring onions, spinach. June: beets/beetroot, broccoli, cabbage, carrots, cron, oregano, peas, strawberries, zucchini blossoms. July: apples, basil, blueberries, blackberries, cherries, cucumbers, eggplants/aubergines, garlic, green beans, melons, onions, peaches, peppers(sweet), potatoes, raspberries, squash(summer), tomatoes, zucchini/courgettes, courgette flowers.
August: broccoli raab, cantaloupes, cauliflower, celery, currants, leeks, nectarines, okra, pears,  plums, squash(winter), turnips, watermelon.
September: Brussels sprouts, escarole, grapes, pumpkins, radicchio, shelling beans/shell beans. October: cranberries and fennel.

For the Southern Hemisphere, starting on:
January: apricots, asparagus, bananas, basil, blackberries, blackcurrants, blueberries, cantaloupes, celery, cherries, cucumbers, eggplants/aubergines, garlic, grapes, green beans, leeks, mangoes, nectarines, okra, peaches, pears, pineapples, plums, radishes, raspberries, red onions, redcurrant, scallions, snake beans, squash (pattypan), strawberries, sweet corn, tomatoes, watermelon, zucchini/courgettes, zucchini blossoms/courgette flowers.
February: apples, onions.
March: avocados, cabbage, kiwi fruit, lettuce, mushrooms (boletes, field, pine), potatoes, pumpkins. April: carton, fennel, parsnips, spinach.
May: turnips.
June: broad beans, broccoli, Brussels sprouts, cauliflower, kale, mandarins.
July: grapefruit (pink), peas.
September: mushrooms (morel).

Need more information about harvest in your area, do your search to find the best grown food for your body.

There are some diets that propose to reduce or eliminate the consumption of a specific nutrient, like for example sugar or carbohydrates. Your body will find a way to produce what you are not providing. If sugar is restricted your body will use your body fat ( or proteins when. Fat is not available) to produce carbohydrates and by doing this conversion the body will lose strength and this may not be healthy. In short eating healthy menas to measure everything that you plan to eat and your body needs measured and balanced amounts of all natural nutrients. What you do not need to eat is processed foods that contain chemically altered nutrients or or synthetic nutrients or substitutes like in the case if sugar. Natural sugar is the best source of carbohydrates but use with measure. 
How much carbs/sugar is recomended (this includes fruits, vegetables and other foods): the maximum amount of sugars you can eat in a day are : Men: 150 calories per day (37.5 grams or 9 teaspoons) Women: 100 calories per day (25 grams or 6 teaspoons). Again use caution if you have a disease and measure using a cup or spoon the amount of each food and know the contents 9carbs, fat, protein)of each food you plan to eat. There are tables with the contents of each nutrient for almost each type of food, do your work and search for this table or consult with your Professional Nutritionist.

Want to read more about the treatment alternative to help you get the best possible outcome for your chronic disease:




Dr.Donato Perez Garcia, MD

What are the advantages of doing a chemo sensitivity test before your IPTLD treatment?

The chemrsensitivity test  provides information and guidance about the drugs that may be suited to the individual in a clinical practice. Standard oncology rely on the statistical analysis of a large treatment trials to decide which drugs to use for specific cancers. Doing the chemrsensitivity testing involves testing an individual cancer cells in the laboratory to see which drugs and which natural substances demonstrate the best response. A similar test is used to find which antibiotic is the right one to use for a particular type of bacteria causing an infection and which is antibiotic is already resistant.

Circulating tumor cells are the one that have detached from the primary tumor and flow into the blood or lymphatic circulation creating a secondary tumor. Despite their rare population, these cells exhibit metastatic attributes and are related to cancer progression. These cells can be isolated and identified for the following purposes:
1- early detection and diagnosis of new cancers
2- monitoring existing cancers
3- prognosis by providing information about the risk of recurrence of a current or old cancer.

If you have cancer this test, that helps for the molecular detection of disseminated cancer cells in the blood stream allow for the identification of a probable high risk of relapse. This test also determine the therapies most likely to be effective against your type of cancer and provides a molecular analyses for the expression of drug targets and chemo-resistance markers in the tumor cells. The test is performed by drawing blood from the patient.
The test is carried out by a few Laboratories in the world (BIOFOCUS, Germany; RGCC GROUP, Greece; LYMPHOCITE, Mexico) all providing a useful information for the selection of drugs that will have the best result for the specific cancer cell type. 

Want to find more if you can benefit from a treatment alternative that will get you the best possible outcome for your disease:




Dr.Donato Perez Garcia, MD.

Tuesday, April 2, 2019

A brief comment on Who is Who in Insulin Potentiation Therapy (IPT or IPTLD)

The Discoverer of Insulin Potentiation Therapy was the late Donato Perez Garcia, MD (1896-1971).
Forty-eight years after his death, I am proud to represent the legacy of my grandfather and my father after him, since becoming licensed as a physician in 1983. This legacy is a unique one, with father passing along to son the gifts, wisdom, and knowledge gained only through many years of invention, triumphs, and struggle in the practice of medicine.
I seek to pass along the same hard fought wisdom, knowledge, and gifts through our Insulin Potentiation Therapy training and certification program, offered in concert with the European Academy for IPT (EAIPT). Certified IPT Practitioners who have successfully completed and maintained their education in the practice of the therapy are listed on the Academy for IPT Directory website, at: 

Donato Perez Garcia, MD

Monday, March 6, 2017

Does Insulin Potentiation Therapy work?

The following is a rebuttal to self proclaimed "medical writters" about Insulin Potentiation Therapy IPT or IPTLD.

I will start by sharing a comment made by R.W. Moss about chemotherapy (extract reproduced from a public source at http://www.whale.to/c/moss.html): “RM: Chemotherapy is machismo practiced to the N'th degree. It is a war in which you are the battleground, lucky you, I mean you have to treat your body better than that. The folks that bring you the toxic chemicals that cause the cancer are then kind enough to bring you toxic chemicals that allegedly…..”

 Yes IPT/IPTLD works, it is a treatment alternative for lasting and successful outcomes. #InsulinPotentiationTherapy #IPT© or #IPTLD®, it is a metabolic supported chemotherapy. It involves fasting, insulin and chemotherapy. This is not a miracle product or the cure that is hidden from you. It is a safe treatment alternative. Not all patients will benefit. Consult your case: www.iptldmd.com

I have undertaken to write this rebuttal because insulin potentiation therapy (IPT/ IPTLD) has helped multitudes of people with cancer who had already undergone the conventional route of surgery, chemotherapy and radiation and whose oncology team explained that there was “nothing else we can do.” I have personally had hundreds of these types of patients come to our center and, guess what? There was and is something that can be done to be restored to health.
It is clear that the self called "medical writers" and editors R.Baratz, RW Moss, J Jones, have not studied the protocols or the science behind insulin potentiation therapy (IPT/IPTLD). Their position regarding IPT/IPTLD as reflected in their writings posted on their Blogs has either evolved out of hearsay or their imagination, not honest research into the subject matter, which indicates that they are attempting to alter people’s opinion regarding this chemotherapy delivery system by ‘reference to “authority,” rather than by utilizing factual information in an effort to inform or educate. The following is a definition of this fallacious way of arguing utilized by Dr Baratz, MD, DDS, PhD:
“Argument from authority (also known as appeal to authority) is a fallacy of defective induction, where it is argued that a statement is correct because the statement is made by a person or source that is commonly regarded as authoritative. The most general structure of this argument is:

 * Source A says that p is true.
 * Source A is authoritative.
 * Therefore, p is true.
This is a fallacy because the truth or falsity of a claim is not related to the authority of the claimant, and because the premises can be true, and the conclusion false (an authoritative claim can turn out to be false). It is also known as argumentum ad verecundiam (Latinargument to respect),argumentum ad potentiam (Latin: argument to power), or ipse dixit (Latin: he himself said it).”
Even a cursory evaluation of the science underlying IPT/IPTLD reveals that all cancer cells studied have, not only many more insulin receptors on their surfaces, but that those receptors have up to a 60% greater affinity (stickiness) than usual insulin receptors on non-cancerous cells. Also, what becomes clear from an earnest evaluation of the research into this matter is that there is a 43% homology between insulin receptors and IGF-1 receptors. This aspect of receptor status regarding cancerous cells is an additionally, rather salient aspect of how it is that IPT/IPTLD works to target cancerous cells as well as increase the effectiveness of the chemotherapeutic agent(s) administered. Under these conditions, lower administered doses carry equal, if not more of a “punch.” IGF-1 receptors, once activated, initiates cells to begin dividing, which is a stage of the cell cycle wherein cells are more vulnerable, hence more easily and effectively eliminated. Although cancerous cells have an autocrine function (produce their own insulin and IGF=1), this is occurring at all times which stimulates and fuels their growth during all phases of the cell cycle. However, when this is purposely activated during treatment with a cytotoxic agent, there is greater destruction of the malignant cells being targeted.
Any physician who has worked in an emergency department knows that when a patient arrives in an unconscious condition, the standard protocol usually calls for a dose of naltrexone and a dose of glucose. The naltrexone to counteract opiate overdose and the glucose counteract insulin overdose. The protocol requires both of these agents since there is no information regarding how the person became unconscious. When glucose is administered intravenously (IV) to someone who is suffering from an insulin overdose, they quickly begin to regain consciousness and are often confused, wondering where they are and how they got there. In the vast majority of cases, the person who was “comatose” (unconscious) from insulin having produced a potentially lethal hypoglycemic state returns to normal with no long term, adverse effects. Although the duration that the person was “comatose” is never precisely known, clearly, it must have included, at least a few minutes prior to the ambulance’s arrival plus the duration of the ambulance ride to the ER.
With insulin potentiation therapy (IPT/IPTLD), no one is ever allowed to become, even slightly neurologically impaired and, of course never allowed to lose consciousness. IV glucose is administered immediately if even the slightest neurological impairment becomes evident, e.g., slurred speech and glucagon is available to be used if the glucose does not immediately reverse the condition. Although glucagon is always available, it has never been necessary to use it. Glucagon is a hormone like insulin, produced in the pancreas by the Islets of Langerhans cells. Insulin is produced by the beta cells while glucagon is produced by the alpha cells. They are the ‘yin and yang’ of blood glucose homeostasis. Glucagon has the opposite effect of insulin and therefore, is its natural ‘antidote.’ NO ONE HAS EVER DIED FROM INSULIN POTENTIATION THERAPY. The same cannot be said of conventionally delivered, high dose chemotherapy. As indicated previously, even a cursory evaluation of the protocols used in IPT/IPTLD make it clear that this concern discussed in Blogs like Quack Watch, Moss Reports regarding the potential neurological impairment resulting from acute hypoglycemia brought about by insulin from this therapeutic modality could never occur if one follows the established protocols.
Why have there been no clinical trials using insulin potentiation therapy? As is commonly known, most clinical trials are expensive and funded by pharmaceutical companies attempting to receive FDA approval for use of a drug or device. No pharmaceutical company has to date accepted the offer to fund a clinical trial utilizing IPT/IPTLD nor even attempted to develop a clinical trail in order to prove that one can use 90% less of a chemotherapeutic drug that has already received FDA approval for its use. The stockholders simply would not allow this. It would not be considered a fiscally sound use of corporate money. The only human trail was performed in Uruguay and funded by the government (reference included). The lead investigator, Dr Lasalvia, is a well respected member of the American Society of Clinical Oncology and the results of his small trail clearly demonstrated that insulin plus a lower dose of a chemotherapeutic agent was more effective than either the drug alone or insulin alone. Although there are similar trials being performed in other countries where funding can be obtained from sources other than pharmaceutical companies, none of the studies have been concluded at this time.
In conclusion, IPT/IPTLD has been used successfully since 1930. Since 1997 it was introduced to many countries for neurological infectious, other infectious diseases, i.e., Lymes, and cancer of almost every type, and all stages (I – IV). With this long history of successful use of a modality to deliver drugs in a targeted fashion, minimal side effects (toxicities) and with no deaths, it is truly a human tragedy that this modality has not been evaluated here in the United States beginning with animal models and progressing to humans, as do all of the drugs that receive FDA approval. To merely criticize and attempt to dissuade further evaluation of something with such great potential benefit to humans is not only a tragedy but should be an embarrassment to the scientific community at large.

How very easy it is to proclaim your self a “medical writer or critic” and think you can rule a lifetime legacy as “quackery”. These ignorant “critics” do a couple of Google searches, a few hour research on an 8-decade tradition and actually believe they are experts in the theme.
What a truly pathetic existence they must have.

The good name of my grandfather and my father have been under attack for decades now, attack on my protocol “Insulin Potentiation Therapy” and this will be tolerated no more.

Self proclaimed medical writers that abuse of their (?) prestige, like Robert Baratz, Jonathan Jones and Ralph W Moss, come out!
They have been attacking my lifetime work and placing doubt over the effectiveness of IPT©- IPTLD® with no solid foundation, except non-medical opinions. But these are the “low blows” of a coward, who attacks behind comfortable desks and think they can undo a lifetime achievement from a laptop and steal a life saving treatment to cancer patients.

The testimony of IPT©- IPTLD® s effectiveness is living and breathing in every cancer patient that lives today in remission, beating in every healthy patient worldwide who overcame cancer when no other doctor gave them hope. IPT©- IPTLD® is hope and mere verbal attacks from you ignorant selfish people, who have no courage to tell it to my face, can undo. My office is open for discussion with you “Quackery Cowards” and dare to say these things to my face. I am not hiding like you are.

Unlike you people, I do have moral standards and courage to fight my opponents out in the open. I do not hide behind comfortable desks, I don’t offend or attack other professional’s based on Google searches and post whatever comes to mind. You are dealing with human lives, and they have the right to know TRUTH, and the TRUTH is that IPT©- IPTLD® is a successful alternative cancer treatment, proven for decades to save patients lives. The theoretical proof is here in my office, if you want it, come and get it! Stop tainting my family’s good name and stop poisoning peoples mind with LIES, take a stand and come out you Cowards! You’ve done enough damage. Think you know more about IPT? PROVE IT!

Publications and Essays on IPT, also Supportive Studies – Published clinical and in-vitro studies that support the use of  insulin as a biologic response modifier.

1)Poster Presentation at the Third Annual Comprehensive Cancer Management Conference, Washington, DC June 2000
Primary Breast Conserving Treatment for Breast Cancer Using Biologic Response Modification with Insulin in Combination with Non-Toxic Low-Dose Chemotherapy. Steven G. Ayre, M.D.

2)Insulin Shows Promise
Oncology News, 1991, 17(4):1,7

3) Ayre SG, Perez Garcia y Bellon D, Perez Garcia Jr D.  Neoadjuvant low-dose chemotherapy with insulin in breast carcinomas.  Eur J Cancer. 26:1261-2, 1990

4) Ayre SG, Perez Garcia Y Bellon D, Perez Garcia Jr D.  Insulin potentiation therapy:  a new concept in the management of chronic degenerative disease.  Medical Hypotheses 20:199-210, 1986

5) Lippman ME, Dickson RB, Kasid A, et al.  Autocrine and paracrine growth regulation of human breast cancer.  J Steroid Biochem 24:147-154, 1986

4) Hilf R.  The actions of insulin as a hormonal factor in breast cancer.  In:  Pike MC, Siiteri PK, Welsch CW, eds.  Hormones and Breast Cancer, Cold Spring Harbor Laboratory, 1981, 317-337.

6) Cullen JK, Yee D, Sly WS, et al.  Insulin-like growth factor receptor expression and function in human breast cancer.  Cancer Res 50:48-53, 1990

6) Holdaway IM, Freisen HG.  Hormone binding by human mammary carcinoma.  Cancer Res 37:1946-1952, 1977

7) Papa V,  Pezzino V, Constantino A, et al.  Elevated insulin receptor content in human breast cancer.  J Clin Invest 86:1503-1510, 1990

8) Sporn MB, Todaro GJ.  Autocrine secretion and malignant transformation of cells.  N Engl J Med 308:487-490, 1980

9) Jaques G, Rotsch M, Wegmann C, et al.  Production of immunoreactive insulin-like growth factor 1 and response to exogenous IGF-1 in small cell lung cancer cell lines.  Exp Cell Res 176:336-343, 1988

10) Nakanishi Y, Mulshine JL, Kasprzyk PG, et al.  Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.  J Clin Invest 82:354-359, 1988

11) Lee PDK, Rosenfeld RG, Hintz RL, Smith SD.  Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.  J Clin Endocr Metab 62:28-35, 1986

12) Colman PG, Harrison LC.  Structure of insulin/insulin-like growth factor-1 receptors on the insulinoma cell, RIN-m5F.  Biochem Biophys Res Commun 124:657-662, 1984

13) Zapf J, Froesch ER.  Insulin-like growth factors/somatomedins:  structure, secretion, biological actions and physiological role.  Hormone Res 24:121-130, 1986

14) Papa V, Constance CR, Brunetti A, et al.  Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinomas.  Cancer Res 50:7857-7862, 1990

15) Stewart AJ, Johnson MD, May REB, Westley RB.  Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.  J Biol Chem 265:21172-21178, 1990

16) Eppenberger U.  New aspects in the molecular growth regulation of mammary tumors.  In:  Eppenberger U, Goldhirsch A, eds.  Recent Results in Cancer Research, Vol. 113:  Endocrine Therapy and Growth Regulation of Breast Cancer.  Berlin-Heidelberg, 1989, 1-3

17) DeLeon DD, Bakker B, WIlson RL, et al.  Demonstration of insulin-like growth factor (IGF-I and IGF-II) receptors and binding protein in human breast cancer cell lines.  Biochem Biophys Res Commun 152:398-405, 1988

18) Karey KP, Sirbasku DA.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17B-estradiol.  Cancer Res 48:4083-4092, 1988

19) King GL, Kahn CR, Rechler MM, Nissley SP.  Direct demonstration for separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor.  J Clin Invest 66:130-140, 1980

20) Jacobs S, Cook S, Svoboda M, Van Wyk JJ.  Interaction of the monoclonal antibodies alpha-IR-1 and alpha-IR3 with insulin and somatomedin-C receptors.  Endocrinol 118:223-226, 1986

21) Goustin AS, Leof EB, Shipley GD, Moses HL.  Growth factors and cancer.  Cancer Res 46:1015-1029, 1986

22) Unterburger P, Sinop A, Noder w, et al.  Diabetes  mellitus  and  breast  cancer:  a retrospective follow-up study.  Onkologie 13:17-20, 1990

23) Yee D, Palk S, Lebovic GS, et al. Analysis of insulin-like growth-factor I gene expression: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517, 1990

24) Hilf R.  Primary and permissive actions of insulin in breast cancer.  In:  Leung BS, ed.  Hormonal regulation of mammary tumors.  Montreal, Eden Press, 1982, Vol. 2, 123-137

25) Alabaster O, Vonderhaar BK, Shafie SM.  Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells.  Eur J Cancer Clin Oncol 17:1223-1228, 1981

26) Oster JB, Creasey WA.  Enhancement of cellular uptake of ellipticine by insulin preincubation.  Eur J Cancer Clin Oncol 17:1097-1103, 1981

27) Schilsky RL, Bailey BD, Chabner BA.  Characteristics of membrane transport of methotrexate by cultured human breast cancer cells.  Biochem Pharmacol 30:1537-1542, 1981

28) Shinitzky M, Henkart P.  Fluidity of cell membranes – current concepts and trends.  Int Rev Cytol 60:121-147, 1971

29) Jeffcoat R.  The biosynthesis of unsaturated fatty acids and its control in mammalian liver.  Essays Biochem 15:1-36, 1979

30) Gasparro FP, Knobler RM, Yemul SS, Bisaccia E, Edelson RL.  Receptor mediated photo-cytotoxicity:  synthesis of a photoactivatable psoralen derivative conjugated to insulin.  Biochem Biophys Res Comm 141:502-209, 1986

31) Poznansky MJ, Singh R, Singh B.  Insulin:  carrier potential for enzyme and drug therapy.  Science 223:1304-1306, 1984

32) Ayre SG.  New approaches to the delivery of drugs to the brain.  Med Hypotheses 29:283-291, 1989

33) Gross GE, Boldt DH, Osborne CK.  Perturbation by insulin of human breast cancer cell kinetics.  Cancer Res 44:3570-3575, 1984

34) Paridaens R, Klijn JGM, Julien JP, et al.  Chemotherapy with estrogenic recruitment in breast cancer:  experimental background and clinical studies conducted by the EORTC breast cancer cooperative group.  Eur J Cancer Clin Oncol 22:728, 1986

35) Van der Burg B, de Laat SW, van Zoelen EJJ.  Mitogenic stimulation of human breast cancer cells in a growth-factor defined medium:  synergistic action of insulin and estrogens.  In:  Brescani F, King RGB, Lippman ME, Raynaud JP, eds.  Progress in Cancer Research and Therapy, vol. 35:  Hormones and Cancer 3.  New York, Raven Press, Ltd.  1988, 231-233.

36) Goldfine ID, Purello F, Vigneri R, and Clawson GA.  Direct regulation of nuclear functions by insulin:  relationship to mRNA metabolism.  In:  Czech MP, ed. Molecular Basic of Insulin Action.  New York, Plenum Press, 1985, 329-345.

37)Blood Brain Barrier Passage of Azidothyumidine in Rats: Effects of Insulin
Steven G. Ayre (1), Brian Skaletski (2) and Aron D. Mosnaim( 2).
Research Communications in Chemical Pathology and Pharmacology JANUARY 1989 VOL.63, NO. 1. Departments of Family Medicine and Pharmacology and Molecular Biology , University of Health Sciences/The Chicago Medical School, North Chicago, IL 60064.

38)New Approaches to Delivery of Drugs to the Brain. S.G. Ayre. Medical Hypotheses 29:283-291, 1989

39)Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer. S.G. Ayre, M.D., D. P. Garcia Bellon, M.D., D. P. Garcia, Jr., M.D. Medical hypotheses 55.4 (2000): 330-334.

40)Low dose chemotherapy in combination with insulin for the treatment of metastatic tumors: C. Damyanov, M. Radoslavova, V. Gavrilov, D. Stoeva. Medical Center of Integrative Medicine, Sofia, Bulgaria. Journal of BUON 14: 711-15, 2009.

41)Insulin Potentiation Therapy in the treatment of malignant neoplastic diseases: a three year study. Damyanov C, Gherasimova DM, Avramov LA, Masley IK (2012). J Cancer Sci Ther 4: 088-091. doi:10.4172/1948-5956.1000117

42)Low-Dose Chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer. Damyanov, Christo, et al. ISRN urology 2012 (2012).

43)Metabolic Modification by Insulin Enhances Methotrexate Cytotoxicity in MCF-7 Human Breast Cells. Alabaster, O. Vonderhaar, B. and Shafie, S. Eur J Cancer Clin Oncol. Vol 17, No. 11, pp 1223-1228. 1961.

44)Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I. Clin Cancer Res. 2007 May 1;13(9):2699 706.

45)Long-Term Effect of Diabetes and Its Treatment on Cognitive Function. Jacobson, Alan, et.al. N Engl J Med 2007; 356:1842-52.

46)Preclinical safety and antitumor efficacy of insulin combined with irradiation. Bénédicte F. Jordan, Nelson Beghein, Nathalie Crokart, Christine Baudelet, Vincent Gregoire, Bernard Gallez. Radiotherapy and Oncology 81 (2006) 112–117.

47)Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Lasalvio-Prisco, Eduardo, et.al. Cancer Chemother Pharmacol (2004) 53: 220–224.

48)The effect of insulin on chemotherapeutic drug sensitivity in human esophageal and lung cancer cells. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):195-7.

49)Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Zou K, Ju JH, Xie H. Acta Pharmacol Sin. 2007 May; 28(5):721-30.

50)A pilot study of Auron Misheil Therapy (AMT) in patients with advanced cervical cancer: tumor response and its correlation with clinical benefit response, and preliminary quality of life data.” Scheele, Jürgen, et al. Oncology reports 22.4 (2009): 877-883.

51)Insulin in endometrial carcinoma chemotherapy: A beneficial addition and not a problem. Sha, Huilan, et al. Journal of Huazhong University of Science and Technology [Medical Sciences] 30 (2010): 631-637.

52) Insulin for Everything. TIME magazine April 10, 1944

53)Long-Term Outcomes of the Treatment of Unresectable (Stage III - IV)Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study. Mehmet Salih Iyikesici1, Ayshe Slocum2*, Engin Turkmen3, Ovunc Akdemir4, Abdul Kadir Slocum5, Turgut Ipek6, Erhun Eyuboglu6, Ferhan Bulent Berkarda7.

How to get in touch with Donato Perez Garcia, MD.

Email: drdonato3@iptldmd.com
Mobil phone: 664-228-3367
Assistant Email: info@iptldmd.com

Medical Office
 Consultorio #505. Hospital Angeles Tijuana
Phone: +52-1-(664) 616-4878
Phone: +51-(664) 635-1827
Skype Phone USA: (619) 798-8017

Web pages:

IPT E-Booklet: http://issuu.com/iptldmd/docs/ipt_ebooklet/1

Social Network:



YouTube: Patient Testimonials and Educational videos about IPT/IPTLD




Blogs: “IPTLD for Cancer and Chronic Degenerative Diseases Treatment by Donato Perez Garcia, M.D.”

Radio Shows
Donato Perez Garcia, MD.

Sunday, January 22, 2017

Lung cancer: Hope for health; true life stories of real people, recovering my health, yes it is possible, no need to be rich and famous to afford this program.

MY EXPERIENCES WITH IPT AS A PATIENT OF DR. DONATO PEREZ GARCIA III. I am a lung cancer free, survivor patient of 24 years treated with IPT/IPTLD.

A Patient Testimonial.

Dr. Donato, quite simply, saved my life! I will always be grateful to him, he will always hold a special place in my heart.
Back in 1992, I was diagnosed with lung cancer. I went through the standard medical routine because of pressure from my family and my Doctor. The first step was a lung biopsy. Terrible experience, my lung was perforated during the procedure: it feels like dying, sudden shortness of breath, losing consciousness. Becuase of the lung biopsy an unexpected 5 day hospital stay, as a life threatening emergency because of the lung puncture, my sister who lives in California told me about this doctor Donato Perez Garcia, MD in Tijuana, Mexico and his treatment alternative.

Back in that year, 1992, doing a research on the internet was not possible, but suddenly a few people started to comment that they knew or heard about this treatment the was originally invented by the late Dr. Donato Perez Garcia, MD (1896-1970) the grand father of today's Dr. Donato. Some even mentioned names of Mexican celebrities, like Palillo an Actor, that were treated with success by Dr. Donato. I also found that another Dr. Donato Perez Garcia Y Bellon who was the son of the inventor and the father of today Dr. Donato continued with the treatment. At some point I had several good comments about going to see Dr. Donato in Tijuana and start his IPT treatment. Glad I did it. I am alive as of November 2016. Yes more than 24 years have passed and I am still a warrior and survivor. I have  seen my children grow, seen and enjoyed my grand children, my family, my friends. I can say that all the other patients I meet diagnosed with cancer and treated at other places during the past 24 years are dead. In contrast many (or the majority) of the patients that I meet during my treatments with Dr. Donato in Tijuana are still alive and yes also some have passed away.

And in terms of costs: I live in Texas, flying for my appointments, lodging in Tijuana , hospital and doctor fees it was affordable, his fees are very reasonable and compared to the local costs in Texas versus the costs of Dr. Donato in Tijuana,  there is such a big difference that makes his IPT treatment alternative the way to go. #InsulinPotentiationTherapy #IPT© or #IPTLD®, it is a metabolic supported chemotherapy. It involves fasting, insulin and chemotherapy. This is not a miracle product or the cure that is hidden from you. It is a safe treatment alternative. Not all patients will benefit. Consult your case: www.iptldmd.com .The treatment administered by Dr. Donato uses FDA and Mexican Health Department approved  pharmaceutical grade drugs.  

November 24, 2016. Teresa Miller, Nurses: Carmen, Cinthia, Mariana and Donato Perez Garcia, MD.
Thank you Dr Donato.
With love and affection, Mrs Teresa Miller.
November 24, 2016 (after 24 years of a healthy life)

Friday, July 22, 2016

Can breast cancer be cured and breast preserved. My story is one of joy, success and another prove that the treatment my doctor administers is safe and effective.July 19,2016.

I no longer have a tumor "cancer" in my left breast. A true story. July 19, 2016. www.iptldmd.com

I'm Alize and I want to share my story. I realized that since 1999 I started to notice that my left breast had a slight feeling of heaviness. I decided to only change my diet and take some herbal remedies. This discomfort remained unchanged until July 2015 at that time it was a more intense heaviness and swelling of the left breast was added. I went to visit my doctor, he recommended to make me tests. A biopsy in August 7, 2015 reported that I had infiltrating ductal carcinoma in the left breast. On September 9, 2015  a PET Scan showed the tumor in the left breast (see photography a yellow red spot in the chest , red circle to show where the tumor was) . In fear for my life as told my the Oncologist I accept to start with standard chemotherapy treatment under the professional care of this traditional oncologist. The first round went wrong, I felt terrible, I had a severe reaction that my life was endangered, they stopped the administration of the drugs. I did not tolerated and decided not to continue with traditional chemotherapy by the end of September of 2015. Next thing to do was to resume natural therapies, substances, vitamin C and other supplements that I was told to try. Although I felt some relief in the breast, the swelling and inflammation did not improve and the tumor started to be felt bigger. Yes I was afraid. In early December of 2015 I was told to seek the opinion of a medical doctor in Mexico with a 33 year experience in a targeted medical treatment that has helped many patients. So I went ahead and first visited his website (www.donatoperezgarcia.com) and decided to try, why not, nothing to lose and no other choices to follow. The first consultation he gave me was on January 8, 2016 where he reviewed my case and my physical condition. It was not until February 4, 2016 that he could give me the first appointment to begin treatment. I followed his instructions, took all his prescription medicines, received his IV targeted low dose chemotherapy or IPTld with minimal side effects, all well tolerated, no hair loss, no nausea. Of course I had my doubts, I heard unfavorable comments. I thought I would have to end up in an operating room to have a mastectomy feeling mutilated, but if this treatment did not work for me it is my life. I did not expect to see my doctor to be supervising my treatments, listening to me, was a good experience because I felt this doctor cares yes Dr. Donato Perez Garcia was always overseeing my treatment and on Friday 24 of June 2016 it was the last treatment he administered to me. He said you need to schedule and appointment to have your 2nd PET Scan to assess the outcome of  my IPT/IPTLD treatment. On July 19, 2016 they gave me the PET Scan results. I am going to keep my left breast, no need for a surgical intervention and yes there is no tumor in the left breast. It seems incredible, tears of emotion, tears of joy and gratitude to Dr Donato Perez Garcia. I know I'm not your first patient in remission there are many and from around the earth (no exaggeration) I feel happy, I got my life back. In his website I read the story of another if his patients Annie Brandt and I never taught that I will be in the same situation, cancer free, breast preserved, got my life and emotions back. Thank you Dr. Donato Perez Garcia, MD. Below are the PET Scan from September 2015 and from July 2016. Inside the red circle a yellow red spot, the tumor as it looked in September of 2015 and an empty red circle in July of 2016. It is real, it's true and it works.

 This is my PET Scan from September 9, 2015, inside the red circle a bright yellow/red spot is seen, this is the tumor my cancer.

 This is my recent PET Scan from July 19, 2016, inside of the red circle no spot can be seen, I no longer have a tumor, my cancer is now in remission. Thanks to Doctor Donato Perez Garcia, MD and his IPT treatment a targeted chemotherapy protocol that delivers chemo drugs just inside of the cancerous cells. This is true. Here is the evidence that in 5 months I recovered my life, my happiness, my joy, and not mutilated. This therapy is targeting chemotherapy to the cancer cells.

July 19, 2016.

Monday, July 4, 2016

Annie Story

Donato Perez Garcia
Hospital Angeles Tijuana
Phone (USA):619.789.8017
Phone (MEX):521.664.616.4878

Annie Story


Dr. Donato, quite simply, saved my life! I will always be grateful to him, he will always hold a special place in my heart, and I will never be able to repay him.
I was diagnosed with advanced-stage breast cancer on Friday the 13th of July 2001, after a biopsy of a swollen lymph node. Because they found it in my lymphatic system, I was automatically at least stage II, with metastatic breast cancer as my diagnosis. The doctor immediately booked me for a double mastectomy, chemo and radiation, starting the following Tuesday. Because I have a dysfunctional immune syndrome as well as several other immune-related diseases, I knew that I had to be careful about what I did to, and put into, my body. After extensive research that weekend, I came to the conclusion that traditional surgery, chemo and radiation would kill me. I decided to try alternative treatments.
I did research and found IPT. I was so excited when I read about this gentle yet effective therapy: kind to the patient, tough on the cancer. It was also important to me that it had been used successfully against cancer for decades.
The doctors found, during further tests, that I had lesions in my brain and my lungs. When I told my doctors about my decision to do IPT instead of conventional, they predicted that I would be dead within six months.
I searched the existing database on GETIPT.com for a doctor near me in Austin, Texas. However, because the website and database were a volunteer effort by one overworked researcher, they were not up-to-date; the doctors listed near me were no longer in practice. Also, because the therapy was still considered “experimental” (even after 70 years in existence and 40 years of use as a successful cancer therapy), my insurance would not pay for any of the treatments. With the overhead of U.S. medical practices, the treatments were more than I could afford.
I decided to call the grandson of the inventor and the most experienced IPT practitioner, Dr. Donato Perez Garcia III, in Tijuana, Mexico. I was used to the lead-time for appointments in the U.S. being several weeks, so he surprised me when he informed me that he could evaluate my case as soon as I could get there. When I asked how long after that I would have to wait for treatment, should he decide to accept me as a patient, he said he could do a treatment the same day as evaluation, if he thought he could help me! The added value was that the overhead is much lower in Mexico, so I could actually imagine affording the treatments.
I made my appointment for later that week. I made both airline and hotel reservations, and I gathered my medical records. The email that Dr. Donato had sent me gave me explicit instructions and directions, so I felt fairly comfortable. I had heard stories about the border cities in Mexico, so I was somewhat concerned, but, again, Dr. Donato put me at ease. 
When I got to Dr. Donato’s office, I was pleasantly surprised to find an office that looked just like any other doctor’s office. The receptionist spoke fluid English, and I was soon shown into Dr. Donato’s office. He spoke with me for a long time, examined my records, and then said he thought he could help me. He asked if I would like to have my first treatment. Having hoped for that eventuality, I had fasted starting at midnight the night before: I was ready!
The treatments are easy and last about 2 hours. I am very comfortable; I usually read a book during the first part of the treatment. Dr. Donato is very available before, during, and after the treatment. He answers all questions and concerns.
The IPT treatments are very gentle. I never lost my hair, and I never got sick. The treatments made the cancer a non-event! I actually considered my treatment trips a mini-vacation! How many times have you heard a cancer patient say that?
I am now totally cancer-free, and all my scans are clear. I will never stop being grateful that I found IPT and Dr. Donato.

Tuesday, June 7, 2016

Low Dose Chemo

Donato Perez Garcia
Hospital Angeles Tijuana

                                        Traditional High/Low Dose Chemo
– Only uses Chemotherapy.
-Traditional Chemo, either in high or low dose, will attack healthy cells, as well as cancerous cells.
-The patient’s level of toxicity will increase and the side effects will decrease the patient’s quality of life.
-Chemo remains in the Extracellular fluid, waiting until cells open up and ingest the anti cancer drugs.
-Because traditional chemo attacks good cells as well as cancerous, the body is weak; the immune system is slower, leaving you unprotected from cancer agents spreading.
-The intervals between Traditional chemotherapy are longer and takes more time for patients to recuperate, extending the length of treatment, and inevitably more expensive in the far future.
– You’ll only get very strong medication, nothing to complement the body’s true healing system.